加载中
NASDAQBasic MaterialsAgricultural Inputs
最新数据
US$0.331
+US$0.0027 · +0.82%
Bioceres Crop Solutions Corp. (BIOX) is a company dedicated to enhancing agricultural output through a diverse range of solutions. Its operations are organized into three principal divisions. The Seed and Integrated Products segment is responsible for creating and bringing to market cutting-edge seed technologies, genetic material, biotechnological innovations, and specialized seed coatings. Under its Crop Protection segment, the company formulates, manufactures, and distributes a comprehensive array of products, including Rizoderma, various adjuvants, therapeutic agents, weed killers, insect eradicators, fungal treatments, and pest lures. The Crop Nutrition unit focuses on the development, production, and distribution of inoculants, bio-stimulants, and both organic and micro-granular fertilizers. A notable offering from Bioceres is HB4, an innovative seed technology engineered for drought resistance. The enterprise maintains a significant presence across several countries, including Argentina, Uruguay, France, and South Africa, alongside broader international operations. Established in 2001, the firm's main offices are situated in Rosario, Argentina. Bioceres Crop Solutions Corp. functions as a subsidiary entity under the umbrella of Bioceres LLC.
前收盘价
US$0.331
+US$0.0027 · +0.82%
盘后
US$0.3347
+US$0.0037 · +1.12%
10月12日 19:48 ET
盘中时间采用ET。市场数据可能有所延迟。
Bioceres Crop Solutions Corp. (BIOX) is a company dedicated to enhancing agricultural output through a diverse range of solutions. Its operations are organized into three principal divisions. The Seed and Integrated Products segment is responsible for creating and bringing to market cutting-edge seed technologies, genetic material, biotechnological innovations, and specialized seed coatings. Under its Crop Protection segment, the company formulates, manufactures, and distributes a comprehensive array of products, including Rizoderma, various adjuvants, therapeutic agents, weed killers, insect eradicators, fungal treatments, and pest lures. The Crop Nutrition unit focuses on the development, production, and distribution of inoculants, bio-stimulants, and both organic and micro-granular fertilizers. A notable offering from Bioceres is HB4, an innovative seed technology engineered for drought resistance. The enterprise maintains a significant presence across several countries, including Argentina, Uruguay, France, and South Africa, alongside broader international operations. Established in 2001, the firm's main offices are situated in Rosario, Argentina. Bioceres Crop Solutions Corp. functions as a subsidiary entity under the umbrella of Bioceres LLC.
日内区间
当前US$0.331
52周区间
当前US$0.331
盘中时间采用ET。市场数据可能有所延迟。
Bioceres Crop Solutions Corp. (BIOX) is a company dedicated to enhancing agricultural output through a diverse range of solutions. Its operations are organized into three principal divisions. The Seed and Integrated Products segment is responsible for creating and bringing to market cutting-edge seed technologies, genetic material, biotechnological innovations, and specialized seed coatings. Under its Crop Protection segment, the company formulates, manufactures, and distributes a comprehensive array of products, including Rizoderma, various adjuvants, therapeutic agents, weed killers, insect eradicators, fungal treatments, and pest lures. The Crop Nutrition unit focuses on the development, production, and distribution of inoculants, bio-stimulants, and both organic and micro-granular fertilizers. A notable offering from Bioceres is HB4, an innovative seed technology engineered for drought resistance. The enterprise maintains a significant presence across several countries, including Argentina, Uruguay, France, and South Africa, alongside broader international operations. Established in 2001, the firm's main offices are situated in Rosario, Argentina. Bioceres Crop Solutions Corp. functions as a subsidiary entity under the umbrella of Bioceres LLC.
日内区间
当前US$0.331
52周区间
当前US$0.331
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目（USD） | 2026财年 | 2025财年 | 2024财年 | 2023财年 | 2022财年 |
|---|---|---|---|---|---|
| 营收 | 2.38亿 USD | 3.33亿 USD | 4.65亿 USD | 4.19亿 USD | 3.28亿 USD |
| 销货成本 | 1.55亿 USD | 2.05亿 USD | 2.83亿 USD | 2.39亿 USD | 2.02亿 USD |
| 毛利 | 8240万 USD | 1.28亿 USD | 1.82亿 USD | 1.8亿 USD | 1.26亿 USD |
| 研究与开发 | — | 1491.48万 USD | 1718.3万 USD | 1534.53万 USD | 694.75万 USD |
| 销售、一般及管理费用 | 8230万 USD | 8834.52万 USD | 9426.66万 USD | 8554.06万 USD | 5735.9万 USD |
| 营业费用 | 8230万 USD | 1.29亿 USD | 1.37亿 USD | 1.12亿 USD | 8490.51万 USD |
| 利息支出 | 5090万 USD | 2562.99万 USD | 2687.2万 USD | 2378.81万 USD | 1792.62万 USD |
| 折旧和摊销 | — | 2218.22万 USD | 2129.53万 USD | 1939.06万 USD | 918.79万 USD |
| 营业利润 | 10万 USD | −76.19万 USD | 4482.1万 USD | 5418.4万 USD | 3986.99万 USD |
| 净利润 | −2.3亿 USD | −5541.61万 USD | 324.3万 USD | 1877.99万 USD | −719.96万 USD |
公司数据更新于 2026年10月13日。
近期已公布业绩
近期已公布业绩
第三方分析师预期可能变化，并非 GoAI 建议。
平均目标
US$8.00
上涨空间 2316.92%报告持有此股票敞口的交易所交易基金。
AI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
